Elizabethkingia meningoseptica Infection in COVID-19 Patients

Bacterial and fungal coinfections including the emergence of antimicrobial resistance are well-recognized in the era of coronavirus disease 2019 (COVID-19) infections. We present three cases of Elizabethkingia meningoseptica (EM), superinfections in COVID-19 patients admitted between the period of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaponda, Mas, Shaukat, Adila, Dulli, Mohammad Wajeh, Sioufi, Stephanie, Al Wali, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663699/
https://www.ncbi.nlm.nih.gov/pubmed/36407258
http://dx.doi.org/10.7759/cureus.30337
Descripción
Sumario:Bacterial and fungal coinfections including the emergence of antimicrobial resistance are well-recognized in the era of coronavirus disease 2019 (COVID-19) infections. We present three cases of Elizabethkingia meningoseptica (EM), superinfections in COVID-19 patients admitted between the period of April 2021 and May 2021. All cases were intubated; had central venous catheters, had received prior antibiotics and antivirals as well as dexamethasone as part of severe COVID-19 management. Only one patient received anakinra. EM isolates were resistant to most available antibiotics and patients infected with it had poor treatment outcomes.

Ejemplares similares